mRNA technology has the potential to combat infectious diseases, cancer, and rare genetic diseases by harnessing the body’s natural...

Allowing pharmacists to “test and treat” for common acute conditions can improve health care access in spite of the primary care shortage.

TCCRI is pleased to release its latest white paper on the need to reform the 340B Program. Below is a one-pager document outlining the...

Congress should take the action necessary to address the four key flaws of the 340B program.

Health insurance mandates drive up the cost of premiums. Filed bills by Sen. Bettencourt and Rep. Paul would require an analysis of new...

Claims that institutional investors are behind this affordability challenge are not supported by the evidence.